Skip to content
OpenCapital
Get started

Ichor Holdings ICHR Issuance of stock under employee stock plans

Issuance of stock under employee stock plans at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$256.1M+4.7%
Gross profit$32.3M+13.1%
Operating income$2.1M+278%
Net income-$2.5M+45.8%
EPS (diluted)-$0.07+46.2%

Balance sheet

See full
Cash & equivalents$89.1M-18.5%
Total debt$158.7M-6.6%
Total equity$668.0M-4.6%
Total assets$972.5M-3.4%

Cash flow

See full
Operating cash flow-$2.9M-115%
CapEx$7.1M-61.8%
Free cash flow-$10.0M-2,113%

Valuation

See full
Market cap$3.21B+110%

Profitability

See full
Gross margin9.5%-2.7pp
Operating margin-3.8%-4.6pp
Net margin-5.3%-11.3pp
FCF margin6.4%+2.2pp

Returns & leverage

See full
Return on equity-7.4%-13.8pp
Debt / equity0.2×0.0×
Current ratio2.8×-0.3×

Where this comes from

Reported directly by Ichor Holdings in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.

The official record: Ichor Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ichor Holdings's issuance of stock under employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ichor Holdings's issuance of stock under employee stock plans?
Ichor Holdings (ICHR) reported issuance of stock under employee stock plans of $4.77M in Q1 2026.
How has Ichor Holdings's issuance of stock under employee stock plans changed year-over-year?
Ichor Holdings's issuance of stock under employee stock plans increased by 19.0% year-over-year, from $4M to $4.77M.
What is the long-term trend for Ichor Holdings's issuance of stock under employee stock plans?
Over 4 years (2021 to 2025), Ichor Holdings's issuance of stock under employee stock plans has grown at a -12.6% compound annual growth rate (CAGR), from $9.66M to $5.63M.